Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKrm22 Plc Regulatory News (KRM)

Share Price Information for Krm22 Plc (KRM)

Share Price is delayed by 15 minutes
Get Live Data
33.50    1.00 (3.08%)
Bid:
32.00
Ask:
35.00
Spread: 3.00 (9.375%)
Market Cap: £19.87m
KRM Live PriceLast checked at - London Stock Exchange

Intraday Krm22 Plc Share Chart

Trading Update

22 Jan 2025 07:00

RNS Number : 1752U
KRM22 PLC
22 January 2025
 

KRM22 plc

("KRM22", the "Group" or the "Company")

Trading Update

 

KRM22 plc, (AIM: KRM) the technology and software investment company with a particular focus on risk management in capital markets, today issues the following trading update for the 12 month period ended 31 December 2024 ("FY2024") with total revenue, Annual Recurring Revenue ("ARR") and adjusted EBITDA all slightly ahead of management's expectations.

 

The Company expects to report audited results for FY2024 in May 2025, and is pleased to report the following financial highlights*:

 

· ARR at 31 December 2024 of £6.6m (FY2023: £5.4m) - growth of 22.2%

New contracted ARR in the year of £1.7m (FY2023: £1.1m)

£1.2m of new contracted ARR generated from direct sales and £0.5m through the relationship with Trading Technologies International, Inc,

· Total revenue recognised of approximately £6.7m (FY2023: £5.3m) - growth of 26.4%

· Adjusted EBITDA: £0.9m (FY2023: loss of £1.4m)

· Gross cash as of 31 December 2024 of £1.0m (FY2023: £0.9m)

· Net debt at 31 December 2024 of £3.5m with the Company having drawn down a total of £4.5m on the debt facility with £0.5m remaining undrawn.

 

The Company has continued to execute on its plan to increase its ARR, delivering £6.6m ARR at FY2024, a net increase of £1.2m from £5.4m at the end of FY2023 and, as at the date of this announcement, the Company's ARR has further increased to £6.8m (£6.7m at FY2024 constant FX rates), with uplifts in contractual ARR from existing customers. The Company now has 44 institutional customers using its applications, of which seven customers have contracts in place for multiple applications.

 

The cost savings plan announced in the February 2024 trading update, with annual cost savings of approximately £1.2m, together with management continuing to tightly manage the cost base of the business and some additional non-recurring revenue has contributed to the Company reporting an adjusted EBITDA profit for FY2024 of £0.9m. 

 

The growth in ARR, continued management of the underlying cost base of the business and the Company's cash balance of £1.0m, together with the availability of £0.5m, which remains undrawn, under the TT convertible loan, means that the Company expects to continue to operate within its existing cash and debt facilities. 

 

Dan Carter, CEO commented: "The continued growth in ARR to £6.6m, surpassing management's expectations of 20% year on year growth, underscores KRM22's progress towards becoming a £10.0m ARR and cash profitable business. The sales pipeline of new opportunities remains strong, and we look forward to converting these opportunities in line with our expectations for 2025."

 

\* The financial expectations noted above are preliminary, and subject to year-end financial close and audit review processes.

 

 

For further information please contact:

 

KRM22 plc

Garry Jones, Chairman

Dan Carter, CEO

Kim Suter, CFO

 

InvestorRelations@krm22.com

Cavendish Capital Markets Limited (Nominated Adviser and Sole Broker)

Carl Holmes / Isaac Hooper / Rory Sale (Corporate Finance)

Sunila de Silva (ECM)

 

+44 (0)20 7220 0500

 

 

The information contained within this announcement was deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 as amended. With the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

 

 

About KRM22 plc

KRM22 is a closed-ended investment company which listed on AIM on 30 April 2018. The Company has been established with the objective of creating value for its investors through the investment in, and subsequent growth and development of, target companies in the technology and software sector, with a focus on risk management in capital markets.

 

Through its investments and the Global Risk Platform, KRM22 helps capital market companies reduce the cost and complexity of risk management. The Global Risk Platform provides applications to help address firms' trading and corporate risk challenges and to manage their entire enterprise risk profile.

 

Capital markets companies' partner with KRM22 to optimise risk management systems and processes, improving profitability and expanding opportunities to increase portfolio returns by leveraging risk as alpha.

 

KRM22 plc is listed on AIM and the Group is headquartered in London, with offices in several of the world's major financial centres.

 

See more about KRM22 at KRM22.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSELFMFEISELF
Date   Source Headline
17th Aug 20207:00 amRNSNew Customer Contract
23rd Jul 202010:49 amRNSIssue of Options
21st Jul 20207:00 amRNSTrading Update
3rd Jul 20201:37 pmRNSHolding(s) in Company
29th Jun 20207:00 amRNSConversion of Convertible Loan Note
25th Jun 202011:51 amRNSResult of AGM
2nd Jun 20207:00 amRNSNotice of AGM and Posting of Annual Report
27th May 20207:00 amRNSSubscription
21st May 20207:00 amRNSAUDITED RESULTS FOR THE YEAR ENDED 31 DEC 2019
20th May 20204:41 pmRNSHolding(s) in Company
19th May 20207:00 amRNSHolding(s) in Company
18th May 20208:53 amRNSHolding(s) in Company
14th May 20207:00 amRNSCompletion of Equity Fundraising
11th May 20207:00 amRNSUpdate on Equity Fundraising
7th May 20202:47 pmRNSStatement re. share price movement
17th Apr 20207:00 amRNSConsolidation of ownership of Irisium Ltd
2nd Apr 20207:00 amRNSDirectorate Changes
2nd Apr 20207:00 amRNSTrading Update
13th Jan 20204:30 pmRNSDirector/PDMR Shareholding
13th Jan 20207:00 amRNSTrading Update
3rd Dec 20197:00 amRNSDirectorate Changes
20th Nov 20198:03 amRNSKRM22 announces Market Risk solution for the GRP
14th Nov 20195:23 pmRNSHolding(s) in Company
7th Nov 20197:01 amRNSKRM22 announces partnership with deltaconX
7th Nov 20197:00 amRNSPlacing
31st Oct 20197:00 amRNSBusiness Update
3rd Oct 20197:00 amRNSNew customer contract
24th Sep 20194:40 pmRNSSecond Price Monitoring Extn
24th Sep 20194:35 pmRNSPrice Monitoring Extension
17th Sep 20197:00 amRNSInterim Results
11th Sep 20197:00 amRNSTrading Update and Notice of Interim Results
6th Aug 20197:00 amRNSKRM22 adds Digital Client Onboarding to offering
11th Jul 20197:00 amRNSPartnership with Quant Foundry
11th Jul 20197:00 amRNSHalf Year Trading Update
28th Jun 201911:52 amRNSResult of AGM
25th Jun 201910:17 amRNSHolding(s) in Company
19th Jun 20197:00 amRNSPartnership with Neotas
6th Jun 20199:00 amRNSNotice of AGM & Posting of Annual Report
6th Jun 20197:00 amRNSSubscription
5th Jun 20196:13 pmRNSHolding(s) in Company
3rd Jun 20197:01 amRNSDirector role change
3rd Jun 20197:00 amRNSFinal Results
3rd Jun 20197:00 amRNSCompletion of Acquisition
31st May 20197:00 amRNSKRM22 announces partnership with Trailight Ltd
30th May 20197:00 amRNSAcquisition of Object+
1st May 20197:00 amRNSUpdate on Fundraising
30th Apr 20197:00 amRNSDirectorate Changes
29th Apr 20197:00 amRNSDebt Facility Secured
16th Apr 20195:30 pmRNSDirector/PDMR Shareholding
16th Apr 201910:00 amRNSKRM22 launches conduct risk training offering

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.